Zobrazeno 1 - 10
of 215
pro vyhledávání: '"K. Ribi"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Richard D. Gelber, Erika Hitre, Andrea Gombos, Alan S. Coates, Alastair M. Thompson, Sole Investigators, Barbara Ruepp, J Chirgwin, Bettina Müller, Marie-Pascale Graas, Stefan Aebi, Subrina Farah, Joaquín Gavilá, Patrick Neven, K. Ribi, A Courtois, Christian Marth, E Abdi, Per Karlsson, Harold J. Burstein, Katsumasa Kuroi, Seamus O'Reilly, A. Goldhirsch, Thomas Ruhstaller, S. Loibl, Manuela Rabaglio, Marco Colleoni, G. Jerusalem, Giulia Viale, C Kamby, Sherene Loi, Edda Simoncini, Meredith M. Regan
Publikováno v:
Annals of Oncology. 32:1256-1266
BACKGROUND Late recurrences in postmenopausal women with hormone receptor-positive breast cancers remain an important challenge. Avoidance or delayed development of resistance represents the main objective in extended endocrine therapy (ET). In anima
Autor:
Jessica C. Stark, Melissa A. Gray, Simon Wisnovsky, Itziar Ibarlucea-Benitez, Nicholas M. Riley, Mikaela K. Ribi, Marta Lustig, Wesley J. Errington, Bence Bruncsics, Casim A. Sarkar, Thomas Valerius, Jeffrey V. Ravetch, Carolyn R. Bertozzi
Despite the curative potential of checkpoint blockade immunotherapy, a majority of patients remain unresponsive to existing treatments. Glyco-immune checkpoints – interactions of cell-surface glycans with lectin, or glycan binding, immunoreceptors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::928a9517f067adedd2fa2500c9f734ce
https://doi.org/10.1101/2022.10.26.513931
https://doi.org/10.1101/2022.10.26.513931
Autor:
Peter A. Szijj, Melissa A. Gray, Mikaela K. Ribi, Calise Bahou, João C. F. Nogueira, Carolyn R. Bertozzi, Vijay Chudasama
Bispecific antibodies (bsAbs) provide enticing therapeutic opportunities in the area of immunotherapy, especially in the field of immuno-oncology. These constructs can bind two separate antigenic epitopes and thus provide access to unique mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a2b277588b7627de23dc9e76a7c3703
https://doi.org/10.26434/chemrxiv-2022-5p97s
https://doi.org/10.26434/chemrxiv-2022-5p97s
Autor:
F. Honecker, A. Müller, S. Schär, L. Rosset, M.N. Corke, M. Schwitter, U. Güth, A. Jakob, C. Balmelli-Cattelan, C. Leo, M. Fehr, D.R. Thorn, S. Riniker, A. Chouiter-Djebaili, J. Musilova, K. Ribi, N. Hoefnagels
Publikováno v:
European Journal of Cancer. 175:S43-S44
Publikováno v:
ESMO open. 7(3)
Weighing risks and benefits is currently the primary criterion for decisions regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the modern immunotherapy- and molecular-targeted driven oncology. Decision aids rarel
Autor:
C.A. Rothermundt, R. Cathomas, K. Gysel, N. Fischer, R. Pereira Mestre, T. Hermanns, S.I. Rothschild, N. Mach, W. Mingrone, M. Ciriolo, B. Müller, A.A. Erdmann, C. Schär, C. Mamot, P. Bohanes, A.G. Omlin, S. Bastian, K. Ribi, S. Gillessen
Publikováno v:
Annals of Oncology. 33:S1429
Autor:
A. Digklia, A. Kollar, M-N. Kronig, C. Britschgi, T. Rordorf, M. Joerger, F. Krasniqi, Y. Metaxas, I. Colombo, D. Dietrich, S. Chiquet, K. Ribi, C.A. Rothermundt
Publikováno v:
Annals of Oncology. 33:S1230
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. Farolfi, Shari Gelber, K. Buser, A. Franzetti Pellanda, Monica Giordano, E. Gallerani, M. Ramello, Vincenzo Bagnardi, K. Ribi, Manuela Rabaglio, Mariangela Ciccarese, Edda Simoncini, Monica Ruggeri, Lorenzo Gianni, Daniel Rauch, N. Bianco, A. Glaus, M. Clerico, A. Freschi, Olivia Pagani, Eleonora Pagan, A. Goldhirsch, Ann H. Partridge, R. Berardi, E. Cretella
Publikováno v:
The Breast. 47:85-92
Objectives Most research addressing needs and concerns of young patients with breast cancer (≤40 years) is retrospective. The HOHO European protocol is a prospective multicenter cohort study of young women with newly diagnosed breast cancer, about